Idexx Laboratories Private Limited, a active foreign private limited company, was established on 17 November 2016 in Bangalore, Karnataka, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U74999KA2016FTC097855. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹7.92 Cr and a paid-up capital of ₹7.92 Cr.
Formerly known as Idexx Laboratories India Private Limited. It upholds a compliant status. Employing 11 professional, Its leadership includes Jeffery Donn Chadbourne (Director), Nilesh Chandrakanth Shah (Director), Lily Joann Lu (Director). Past directors included Nilanjan Ghose, Rabindra Nath Jhunjhunwala, Jeffery Donn Chadbourne. Its latest AGM occurred on 30 October 2024, with the balance sheet filed on 31 March 2024. It is based at Regus, World Trade Centre, 22Nd Floor, Unit No. 2201 A, Brigade Gateway, Malles, Hwaram,, Bangalore, Karnataka, 560055.
U74999KA2016FTC097855
097855
17 November 2016
₹7.92 Cr
₹7.92 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Idexx Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jeffery Donn Chadbourne | Director | 28 Apr 2018 | Current |
| Nilesh Chandrakanth Shah | Director | 18 Sep 2017 | Current |
| Lily Joann Lu | Director | 22 Feb 2019 | Current |
| Ellen Adelaide Arrigoni | Director | 30 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Jan 2017 | Past |
| Pramod Abcsdd | Director | 02 Jan 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 01 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 16 Oct 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Idexx Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.68% increase. The company also saw a substantial improvement in profitability, with a 36.39% increase in profit. The company's net worth moved up by a moderate rise of 9.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Idexx Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Idexx Laboratories has a workforce of 11 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Idexx Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Idexx Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Idexx Laboratories Private Limited last Annual general meeting of members was held on 30 Oct 2024 as per latest MCA records. was completed.
Ellen Adelaide Arrigoni was appointed as a Director was appointed as a Director on 30 Oct 2024 & has been associated with this company since 1 year 28 days . was recorded as a recent event.
Progress on Idexx Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The activity Lily Joann Lu was appointed as a Director was appointed as a Director on 22 Feb 2019 & has been associated with this company since 6 years 9 months . was completed.
Progress on Jeffery Donn Chadbourne was appointed as a Director was appointed as a Director on 28 Apr 2018 & has been associated with this company since 7 years 7 months . was documented.
Progress on Nilesh Chandrakanth Shah was appointed as a Director was appointed as a Director on 18 Sep 2017 & has been associated with this company since 8 years 2 months . was documented.
The CIN of Idexx Laboratories Private Limited is U74999KA2016FTC097855.
Idexx Laboratories Private Limited is headquartered at Regus, World Trade Centre, 22Nd Floor, Unit No. 2201 A, Brigade Gateway, Malles, Hwaram,, Bangalore, Karnataka, 560055.
Idexx Laboratories Private Limited was incorporated on 17 November 2016.
The current directors of Idexx Laboratories Private Limited are
The primary industry of Idexx Laboratories Private Limited is Hospital And Medical Care.
Idexx Laboratories Private Limited is unlisted.
The authorized capital of Idexx Laboratories Private Limited is ₹7.92 Cr, and the paid-up capital is ₹7.92 Cr.
The compliance status of Idexx Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX